We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nobel Prize Awarded for Fundamental Discoveries in the Developmental Capacity of Mature Cells

By LabMedica International staff writers
Posted on 15 Oct 2012
The 2012 Nobel Prize for Physiology or Medicine jointly awarded to scientists John B. More...
Gurdon and Shinya Yamanaka recognizes the fundamental nature of their discoveries about the capacity of mature, specialized cells to be reprogrammed back into immature, pluripotent stem-like cells. The prize also reflects recognition of important progress being made in medical research based on these groundbreaking discoveries.

The process of developing from an immature into a specialized cell was previously considered to be unidirectional and irreversible. It was thought that during maturation the cell undergoes certain changes that include loss of the capacity to return to a pluripotent stage. John B. Gurdon, long-time professor of cell biology at the University of Cambridge (Cambridge, UK) and currently at the Gurdon Institute (Cambridge, UK), challenged this dogma that the specialized cell is irreversibly committed. In 1962, Prof. Gurdon published a landmark study in the Journal of Embryology and Experimental Morphology titled “The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles.” In this classic experiment, he replaced the immature nucleus of a frog egg cell with the nucleus from a mature intestinal cell. This modified egg cell developed into a normal tadpole, showing that the DNA of the mature cell still contained all the genetic information required for the development of all the cells of a fully functional frog. This conclusion was eventually confirmed and generalized to other organisms, including mammals, by independent studies performed by other researchers.

Prof. Gurdon’s experiment involved mechanical removal of intact nuclei from cells and introduction of a nucleus from a specialized cell into a de-nucleated nonspecialized cell. Over 40 years later, Shinya Yamanaka, currently professor at Kyoto University (Kyoto, Japan) and affiliated with the Gladstone Institutes (San Francisco, CA, USA), discovered that it was also possible to reprogram fully intact mature cells to become pluripotent cells by the introduction of only a few specific genes in a specific combination, discovered by testing various combinations from a set of previously identified candidate genes. This groundbreaking study from Prof. Yamanaka’s laboratory was published in 2006 in the journal Cell, titled “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.” These induced pluripotent stem cells (iPSC) have already constituted another breakthrough in developmental biology. And by reprogramming also human cells, scientists have created new opportunities to study human disease mechanisms and develop methods for medical therapy and diagnosis.

Related Links:

Nobel Foundation
Gurdon Institute
Kyoto University



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.